Publication:
CA19-9 and CEA biosensors in pancreatic cancer

Simple item page
dc.citedby15
dc.contributor.authorAhmadipour M.en_US
dc.contributor.authorBhattacharya A.en_US
dc.contributor.authorSarafbidabad M.en_US
dc.contributor.authorSyuhada Sazali E.en_US
dc.contributor.authorKrishna Ghoshal S.en_US
dc.contributor.authorSatgunam M.en_US
dc.contributor.authorSingh R.en_US
dc.contributor.authorRezaei Ardani M.en_US
dc.contributor.authorMissaoui N.en_US
dc.contributor.authorKahri H.en_US
dc.contributor.authorPal U.en_US
dc.contributor.authorLing Pang A.en_US
dc.contributor.authorid55533484700en_US
dc.contributor.authorid57203499788en_US
dc.contributor.authorid56486136100en_US
dc.contributor.authorid58852080700en_US
dc.contributor.authorid57202443208en_US
dc.contributor.authorid48561725600en_US
dc.contributor.authorid57221127160en_US
dc.contributor.authorid57221374739en_US
dc.contributor.authorid57212210643en_US
dc.contributor.authorid57191823566en_US
dc.contributor.authorid8908351700en_US
dc.contributor.authorid58852624900en_US
dc.date.accessioned2025-03-03T07:45:19Z
dc.date.available2025-03-03T07:45:19Z
dc.date.issued2024
dc.description.abstractCancer is a complex pathophysiological condition causing millions of deaths each year. Early diagnosis is essential especially for pancreatic cancer. Existing diagnostic tools rely on circulating biomarkers such as Carbohydrate Antigen 19?9 (CA19-9) and Carcinoembryonic Antigen (CEA). Unfortunately, these markers are nonspecific and may be increased in a variety of disorders. Accordingly, diagnosis of pancreatic cancer generally involves more invasive approaches such as biopsy as well as imaging studies. Recent advances in biosensor technology have allowed the development of precise diagnostic tools having enhanced analytical sensitivity and specificity. Herein we examine these advances in the detection of cancer in general and in pancreatic cancer specifically. Furthermore, we highlight novel technologies in the measurement of CA19-9 and CEA and explore their future application in the early detection of pancreatic cancer. ? 2024 Elsevier B.V.en_US
dc.description.natureFinalen_US
dc.identifier.ArtNo117788
dc.identifier.doi10.1016/j.cca.2024.117788
dc.identifier.scopus2-s2.0-85183542232
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85183542232&doi=10.1016%2fj.cca.2024.117788&partnerID=40&md5=3904274197fc3f069667d4269bb87526
dc.identifier.urihttps://irepository.uniten.edu.my/handle/123456789/36866
dc.identifier.volume554
dc.publisherElsevier B.V.en_US
dc.sourceScopus
dc.sourcetitleClinica Chimica Acta
dc.subjectBiomarkers, Tumor
dc.subjectCA-19-9 Antigen
dc.subjectCarcinoembryonic Antigen
dc.subjectHumans
dc.subjectPancreatic Neoplasms
dc.subjectSensitivity and Specificity
dc.subjectCA 19-9 antigen
dc.subjectcarbon
dc.subjectcarbon nanotube
dc.subjectcarcinoembryonic antigen
dc.subjectfullerene derivative
dc.subjectgraphene
dc.subjectmetal organic framework
dc.subjectmetal oxide
dc.subjectnanomaterial
dc.subjecttransition element
dc.subjecttumor marker
dc.subjectCA 19-9 antigen
dc.subjectcarcinoembryonic antigen
dc.subjecttumor marker
dc.subjectantigen detection
dc.subjectbiological trait
dc.subjectbiotechnology
dc.subjectcancer mortality
dc.subjectcarcinogenesis
dc.subjectclassification
dc.subjectdiagnostic imaging
dc.subjectearly cancer diagnosis
dc.subjectelectrochemical analysis
dc.subjectellipsometry
dc.subjecthuman
dc.subjectinvasive procedure
dc.subjectnonhuman
dc.subjectpancreas biopsy
dc.subjectpancreas cancer
dc.subjectpathophysiology
dc.subjectpoint of care testing
dc.subjectRaman spectrometry
dc.subjectReview
dc.subjectsensitivity and specificity
dc.subjectsurface plasmon resonance
dc.subjecttumor biopsy
dc.subjectpancreas tumor
dc.titleCA19-9 and CEA biosensors in pancreatic canceren_US
dc.typeReviewen_US
dspace.entity.typePublication
Files
Collections
SCOPUS